AXSM Operating Cash Flow (Statement)
Axsome Therapeutics Inc · Operating Cash Flow (Statement)
AXSM Operating Cash Flow (Statement)
Latest reported-$32.95Mperiod ending
AXSM Quarterly Cash from Operations (-$695.96K → -$32.95M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
AXSM operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -32,952,000 | |
| -20,700,000 | |
| -18,653,000 | |
| 1,046,000 | |
| -32,423,000 | |
| -43,375,000 | |
| -26,202,000 | |
| -18,631,000 | |
| -30,110,000 | |
| -53,467,000 | |
| -30,362,000 | |
| -53,548,000 | |
| -55,349,000 | |
| -5,821,000 | |
| -27,563,242 | |
| -22,757,920 | |
| -33,536,656 | |
| -32,652,980 | |
| -28,840,519 | |
| -26,776,203 | |
| -25,393,553 | |
| -27,215,489 | |
| -20,553,517 | |
| -15,734,586 | |
| -18,895,282 | |
| -23,273,184 | |
| -17,567,151 | |
| -10,626,908 | |
| -8,681,790 | |
| -9,499,210 | |
| -9,793,949 | |
| -5,912,033 | |
| -7,667,280 | |
| -6,680,439 | |
| -6,291,230 | |
| -6,447,402 | |
| -7,096,596 | |
| -6,636,424 | |
| -7,216,675 | |
| -4,802,371 | |
| -5,314,649 | |
| -3,947,609 | |
| -2,250,854 | |
| -1,922,463 | |
| -2,106,823 | |
| -1,158,851 | |
| -1,946,893 | |
| -1,257,584 | |
| -695,958 | |
| -695,959 |